# Cineverse Corp.: filings

CNVS · Nasdaq · CIK 1173204 · [Communication](/sectors/communication.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/cnvs.md) · [Financials](/companies/cnvs/financials.md) · [Filings](/companies/cnvs/filings.md) · [Insiders](/companies/cnvs/insiders.md)

## Reports and events: 422 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 275, 4 268, 10-Q 53, 3 29, SC 13D/A 28, CORRESP 25, EFFECT 23, DEF 14A 21, DEFA14A 19, 10-K 18, SC 13G/A 18, UPLOAD 17, 144 13, 424B5 13, 8-K/A 12, SC 13G 12, 424B3 11, PRE 14A 11, S-3 11, 4/A 9, POS AM 9, D 8, S-3/A 8, 424B2 7, SC 13D 7, NT 10-K 6, NT 10-Q 6, ARS 5, CT ORDER 5, S-8 5, SCHEDULE 13G/A 4, 10-Q/A 3, PRER14A 3, DEF 14C 2, DEFR14A 2, PRE 14C 2, S-1 2, S-1/A 2, 10-K/A 1, 3/A 1, 5 1, 8-A12B 1, 8-A12B/A 1, DEFM14C 1, PREM14C 1, REGDEX 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:28 ET | [DEF 14A](/filings/0001193125-26-436230.md) | Proxy statement, period 2026-12-08 | 0001193125-26-436230 |
| 2026-09-17 | 17:00 ET | [8-K](/filings/0001193125-26-394472.md) | 5.07 Shareholder vote results | 0001193125-26-394472 |
| 2026-09-04 | 16:30 ET | [8-K](/filings/0001193125-26-383714.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-383714 |
| 2026-08-13 | 16:45 ET | [10-Q](/filings/0001193125-26-349428.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349428 |
| 2026-08-13 | 16:15 ET | [8-K](/filings/0001193125-26-349221.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349221 |
| 2026-08-10 | 16:30 ET | [DEF 14A](/filings/0001193125-26-342483.md) | Proxy statement, period 2026-08-10 | 0001193125-26-342483 |
| 2026-06-26 | 08:50 ET | [10-K](/filings/0001193125-26-284027.md) | Annual report, period 2026-03-31 | 0001193125-26-284027 |
| 2026-06-26 | 08:15 ET | [8-K](/filings/0001193125-26-283983.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-283983 |
| 2026-05-28 | 16:35 ET | [8-K](/filings/0001193125-26-245350.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-245350 |
| 2026-05-01 | 16:58 ET | [8-K](/filings/0001193125-26-201677.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-201677 |
| 2026-04-15 | 17:09 ET | [8-K](/filings/0001193125-26-157226.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-157226 |
| 2026-02-17 | 17:01 ET | [10-Q](/filings/0001193125-26-055008.md) | Quarterly report, period 2025-12-31 | 0001193125-26-055008 |
| 2026-02-17 | 16:00 ET | [8-K](/filings/0001193125-26-054528.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-054528 |
| 2026-02-17 | 06:05 ET | [8-K](/filings/0001193125-26-052752.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-052752 |
| 2026-02-17 | 21:41 ET | [8-K](/filings/0001193125-26-052164.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-052164 |
| 2026-02-12 | 16:39 ET | [8-K](/filings/0001193125-26-048897.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-048897 |
| 2026-01-13 | 17:00 ET | [8-K](/filings/0001193125-26-011867.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-011867 |
| 2025-11-21 | 17:28 ET | [8-K](/filings/0001193125-25-291646.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-291646 |
| 2025-11-14 | 17:31 ET | [10-Q](/filings/0001193125-25-283349.md) | Quarterly report, period 2025-09-30 | 0001193125-25-283349 |
| 2025-11-14 | 17:21 ET | [8-K](/filings/0001193125-25-283328.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283328 |
| 2025-10-10 | 17:27 ET | [DEF 14A](/filings/0001193125-25-237240.md) | Proxy statement, period 2025-11-20 | 0001193125-25-237240 |
| 2025-09-29 | 17:15 ET | [8-K](/filings/0001193125-25-223433.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-223433 |
| 2025-08-14 | 17:01 ET | [10-Q](/filings/0000950170-25-109033.md) | Quarterly report, period 2025-06-30 | 0000950170-25-109033 |
| 2025-08-14 | 16:31 ET | [8-K](/filings/0000950170-25-108974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108974 |
| 2025-06-30 | 17:27 ET | [10-K](/filings/0000950170-25-091741.md) | Annual report, period 2025-03-31 | 0000950170-25-091741 |
| 2025-06-27 | 09:30 ET | [8-K](/filings/0000950170-25-090622.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-090622 |
| 2025-05-20 | 17:00 ET | [8-K](/filings/0000950170-25-075333.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-075333 |
| 2025-05-07 | 17:07 ET | [8-K](/filings/0000950170-25-065892.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-065892 |
| 2025-04-14 | 17:00 ET | [8-K](/filings/0000950170-25-053766.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-053766 |
| 2025-03-06 | 09:00 ET | [8-K](/filings/0000950170-25-034207.md) | 8.01 Other events | 0000950170-25-034207 |
| 2025-02-14 | 17:00 ET | [10-Q](/filings/0000950170-25-021401.md) | Quarterly report, period 2024-12-31 | 0000950170-25-021401 |
| 2025-02-13 | 17:00 ET | [8-K](/filings/0000950170-25-020015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-020015 |
| 2025-01-06 | 17:52 ET | [8-K](/filings/0000950170-25-001415.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-001415 |
| 2024-11-22 | 17:25 ET | [8-K](/filings/0000950170-24-130297.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-130297 |
| 2024-11-20 | 16:07 ET | [DEF 14A](/filings/0000950170-24-129241.md) | Proxy statement, period 2024-12-30 | 0000950170-24-129241 |
| 2024-11-14 | 17:00 ET | [10-Q](/filings/0000950170-24-127165.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127165 |
| 2024-11-14 | 17:00 ET | [8-K](/filings/0000950170-24-127160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-127160 |
| 2024-10-24 | 17:29 ET | [8-K](/filings/0000950170-24-117123.md) | 8.01 Other events | 0000950170-24-117123 |
| 2024-08-15 | 16:30 ET | [8-K](/filings/0000950170-24-097620.md) | 1.01 Entry into a material agreement | 0000950170-24-097620 |
| 2024-08-14 | 16:50 ET | [10-Q](/filings/0000950170-24-097132.md) | Quarterly report, period 2024-06-30 | 0000950170-24-097132 |
| 2024-08-14 | 16:30 ET | [8-K](/filings/0000950170-24-097087.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-097087 |
| 2024-07-17 | 18:46 ET | [8-K](/filings/0000950170-24-084021.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-084021 |
| 2024-07-12 | 16:50 ET | [8-K](/filings/0000950170-24-083250.md) | 3.01 Delisting notice | 0000950170-24-083250 |
| 2024-07-08 | 08:30 ET | [8-K](/filings/0000950170-24-081952.md) | 8.01 Other events | 0000950170-24-081952 |
| 2024-07-01 | 16:55 ET | [10-K](/filings/0000950170-24-079718.md) | Annual report, period 2024-03-31 | 0000950170-24-079718 |
| 2024-07-01 | 16:50 ET | [8-K](/filings/0000950170-24-079708.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-079708 |
| 2024-05-03 | 17:12 ET | [8-K](/filings/0000950170-24-053036.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-053036 |
| 2024-04-11 | 08:15 ET | [8-K](/filings/0000950170-24-043527.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-24-043527 |
| 2024-03-21 | 18:15 ET | [8-K](/filings/0000950170-24-034318.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-034318 |
| 2024-03-04 | 17:20 ET | [8-K](/filings/0000950170-24-024954.md) | 8.01 Other events | 0000950170-24-024954 |

Page 1 of 9. [Older](/companies/cnvs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.